Why the study?
Does 24-hour blood pressure control with long-acting antihypertensive drugs improve target-organ protection and reduce cardiovascular events in hypertensive patients?
Does 24-hour blood pressure control with long-acting antihypertensive drugs improve target-organ protection and reduce cardiovascular events in hypertensive patients?
Answers are grounded in this paper and cite their sources.
Ambulatory blood pressure monitoring and long-acting antihypertensives are crucial for achieving 24-hour blood pressure control and reducing cardiovascular risk, particularly in non-dippers.
BACKGROUND: The increasing availability of ambulatory blood pressure monitoring has shifted interest in blood pressure measurement from the doctor's office to the entire 24-h period. Routine office blood pressure recordings correlate poorly with left ventricular mass, a sign of early target-organ damage. In contrast, ambulatory blood pressure or estimates of 24-h blood pressure load show a good correlation with left ventricular mass. STUDY FINDINGS: Circadian blood pressure rhythms may be important in determining future cardiovascular events. For example, patients who maintain high nocturnal blood pressures (non-dippers) experience more cardiovascular sequelae than do nocturnal dippers, with women non-dippers having the greatest risk. Longer-acting antihypertensive drugs may return circadian blood pressure rhythms to normal by converting non-dippers to dippers. Adequate control of blood pressure toward the end of each 24-h cycle may reduce the early morning rise in cardiovascular events associated with awakening and ambulation. RECENT ADVANCES: Recent improvements in the estimation of trough to peak ratio have provided a useful arithmetic index for comparing the antihypertensive effects of different compounds over 24-h dosing intervals. Long-acting agents have now been identified in each of the major classes of antihypertensive drugs, making it now possible to maximize target-organ protection by achieving good 24-h blood pressure control in most hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Martin G. Myers (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: